Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-13

Clinical Trial Update: Ventral Hernia Study Using OviTex Reinforced Bioscaffold [NA]

View source ↗

Summary

A completed ventral hernia clinical trial evaluating OviTex reinforced bioscaffold; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OviTex Reinforced Bioscaffold (OviTex reinforced bioscaffold)

Snippet

Sponsor: Tela Bio Inc | Conditions: Hernia, Ventral | NA | Status: COMPLETED | Results posted: 2023-06-13